Literature DB >> 17066970

The impact of a breathlessness intervention service (BIS) on the lives of patients with intractable dyspnea: a qualitative phase 1 study.

Sara Booth1, Morag Farquhar, Marjolein Gysels, Claudia Bausewein, Irene J Higginson.   

Abstract

OBJECTIVE: Disabling breathlessness is the most common symptom of advanced cardiopulmonary disease. It is usually intractable, even when patients receive maximal medical therapy for their underlying condition. A pilot study was undertaken to evaluate a newly formed palliative Breathlessness Intervention Service (BIS).
METHODS: The methodology followed the Medical Research Council's Framework for the Evaluation of Complex Interventions (Phase I). Qualitative interviews were completed with patients and relatives who had used the service and clinicians who had referred to it. The focus of the interviews was the participants' experience of using BIS.
RESULTS: Patients valued the positive educational approach taken to breathlessness, emphasizing what was possible rather than what had been lost. Non-pharmacological strategies, especially the hand-held fan and exercises, were rated very helpful and new to patients. Participants reiterated that breathlessness was frightening and isolating, exacerbating the disability it caused: the easy access to advice and flexibility of BIS helped to alleviate this. Participants wanted a written record of the advice given. Carers welcomed the focus on their needs. Clinicians valued sharing the management of patients with an intractable problem. SIGNIFICANCE OF
RESULTS: This Phase I study has helped to remodel the service rapidly by uncovering the aspects of BIS that users find most valuable and areas that need change or improvement. The BIS needs to provide written information, to reinforce and extend contacts with other agencies to build on support it already provides for patients and carers, and extend its flexibility and accessibility. Providing a "drop-in" service and continuing education after the initial program of contacts is completed could be a useful service development, warranting further evaluation. A qualitative methodology involving service users and referrers can help to shape service development rapidly.

Entities:  

Mesh:

Year:  2006        PMID: 17066970     DOI: 10.1017/s1478951506060366

Source DB:  PubMed          Journal:  Palliat Support Care        ISSN: 1478-9515


  24 in total

1.  Palliative and end-of-life care for patients with chronic heart failure and chronic lung disease.

Authors:  Miriam J Johnson; Sara Booth
Journal:  Clin Med (Lond)       Date:  2010-06       Impact factor: 2.659

Review 2.  WITHDRAWN: Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases.

Authors:  Claudia Bausewein; Sara Booth; Marjolein Gysels; Irene J Higginson
Journal:  Cochrane Database Syst Rev       Date:  2013-11-22

Review 3.  Management of refractory breathlessness in patients with advanced cancer.

Authors:  Steffen T Simon; Claudia Bausewein
Journal:  Wien Med Wochenschr       Date:  2009-12

4.  Perspectives of patients, family caregivers and physicians about the use of opioids for refractory dyspnea in advanced chronic obstructive pulmonary disease.

Authors:  Graeme Rocker; Joanne Young; Margaret Donahue; Morag Farquhar; Catherine Simpson
Journal:  CMAJ       Date:  2012-04-23       Impact factor: 8.262

5.  Toward optimal end-of-life care for patients with advanced chronic obstructive pulmonary disease: insights from a multicentre study.

Authors:  Graeme M Rocker; Peter M Dodek; Daren K Heyland
Journal:  Can Respir J       Date:  2008 Jul-Aug       Impact factor: 2.409

Review 6.  The symptomatic relief of dyspnea.

Authors:  Giovanni Elia; Jay Thomas
Journal:  Curr Oncol Rep       Date:  2008-07       Impact factor: 5.075

7.  Should we measure dyspnoea in everyone?

Authors:  Robert B Banzett; Carl R O'Donnell
Journal:  Eur Respir J       Date:  2014-06       Impact factor: 16.671

8.  Contributions of a hand-held fan to self-management of chronic breathlessness.

Authors:  Tim Luckett; Jane Phillips; Miriam J Johnson; Morag Farquhar; Flavia Swan; Teresa Assen; Priyanka Bhattarai; Sara Booth
Journal:  Eur Respir J       Date:  2017-08-17       Impact factor: 16.671

9.  The feasibility of a single-blinded fast-track pragmatic randomised controlled trial of a complex intervention for breathlessness in advanced disease.

Authors:  Morag C Farquhar; Irene J Higginson; Petrea Fagan; Sara Booth
Journal:  BMC Palliat Care       Date:  2009-07-07       Impact factor: 3.234

10.  Development, effectiveness and cost-effectiveness of a new out-patient Breathlessness Support Service: study protocol of a phase III fast-track randomised controlled trial.

Authors:  Claudia Bausewein; Caroline Jolley; Charles Reilly; Paula Lobo; Jane Kelly; Helene Bellas; Preety Madan; Caty Panell; Elmien Brink; Chiara De Biase; Wei Gao; Caroline Murphy; Paul McCrone; John Moxham; Irene J Higginson
Journal:  BMC Pulm Med       Date:  2012-09-19       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.